Inclusion body myositis: Review of recent literature

被引：18

作者：

Greenberg, Steven A. ^{[1
]}

机构：

[1] Brigham & Womens Hosp, Dept Neurol, Boston, MA 02115 USA

来源：

CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS | 2009年 / 9卷 / 01期

基金：

美国国家卫生研究院;

关键词：

BETA-AMYLOID PRECURSOR; MYXOVIRUS-LIKE STRUCTURES; HUMAN MUSCLE-FIBERS; INFLAMMATORY MYOPATHIES; SKELETAL-MUSCLE; TRANSGENIC MICE; CHRONIC POLYMYOSITIS; MUSCULAR-DYSTROPHY; GENE-EXPRESSION; RIMMED VACUOLES;

D O I：

10.1007/s11910-009-0013-x

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

Inclusion body myositis (IBM) is a progressive inflammatory skeletal muscle disease of unknown cause and without effective treatment. This article discusses existing literature, emphasizing disease mechanisms and models. In particular, it addresses limitations in the beta-amyloid-mediated theory of IBM myofiber injury, flawed rationales of animal models of this disease, and recent reports regarding treatment.

引用

页码：83 / 89

页数：7

共 70 条

[41]

Johnson LG., 2007, Clin Neuromuscul Dis, V8, P187

[42] Casein kinase 1 α associates with the τ-bearing lesions of inclusion body myositis [J].

Kannanayakal, Theresa J. ;

Mendell, Jerry R. ;

Kuret, Jeff .

NEUROSCIENCE LETTERS, 2008, 431 (02) :141-145

[43] Inflammation induces tau pathology in inclusion body myositis model via glycogen synthase kinase-3β [J].

Kitazawa, Masashi ;

Trinh, Dan N. ;

LaFerla, Frank M. .

ANNALS OF NEUROLOGY, 2008, 64 (01) :15-24

[44] Genetically augmenting Aβ42 levels in skeletal muscle exacerbates inclusion body myositis-like pathology and motor deficits in transgenic mice [J].

Kitazawa, Masashi ;

Green, Kim N. ;

Caccamo, Antonella ;

LaFerla, Frank M. .

AMERICAN JOURNAL OF PATHOLOGY, 2006, 168 (06) :1986-1997

[45] UBIQUITIN AND BETA-AMYLOID-PROTEIN IN INCLUSION-BODY MYOSITIS (IBM), FAMILIAL IBM-LIKE DISORDER AND OCULOPHARYNGEAL MUSCULAR-DYSTROPHY - AN IMMUNOCYTOCHEMICAL STUDY [J].

LECLERC, A ;

TOME, FMS ;

FARDEAU, M .

NEUROMUSCULAR DISORDERS, 1993, 3 (04) :283-291

[46] β-amyloid is a substrate of autophagy in sporadic inclusion body myositis [J].

Lunemann, Jan D. ;

Schmidt, Jens ;

Schmid, Dorothee ;

Barthel, Konstanze ;

Wrede, Arne ;

Dalakas, Marinos C. ;

Munz, Christian .

ANNALS OF NEUROLOGY, 2007, 61 (05) :476-483

[47] Expression of transglutaminase 2 does not differentiate focal myositis from generalized inflammatory myopathies [J].

Macaione, V. ;

Aguennouz, M. ;

Mazzeo, A. ;

De Pasquale, M. G. ;

Russo, M. ;

Toscano, A. ;

De Luca, G. ;

Di Giorgio, R. M. ;

Vita, G. ;

Rodolico, C. .

ACTA NEUROLOGICA SCANDINAVICA, 2008, 117 (06) :393-398

[48] Transgenic expression of β-APP in fast-twitch skeletal muscle leads to calcium dyshomeostasis and IBM-like pathology [J].

Moussa, Charbel E-H. ;

Fu, Qinghao ;

Kumar, Pravir ;

Shtifman, Alexander ;

Lopez, Jose R. ;

Allen, Paul D. ;

LaFerla, Frank ;

Weinberg, David ;

Magrane, Jordi ;

Aprahamian, Tamar ;

Walsh, Kenneth ;

Rosen, Kenneth M. ;

Querfurth, Henry W. .

FASEB JOURNAL, 2006, 20 (12) :2165-+

[49] Histone H1 is released from myonuclei and present in rimmed vacuoles with DNA in inclusion body myositis [J].

Nakano, Satoshi ;

Shinde, Akiyo ;

Fujita, Kengo ;

Ito, Hidefumi ;

Kusaka, Hirofumi .

NEUROMUSCULAR DISORDERS, 2008, 18 (01) :27-33

[50]

NALBANTOGLU J, 1994, AM J PATHOL, V144, P874

← 1 2 3 4 5 6 7 →